747 results on '"Ho, Dean"'
Search Results
2. About the Authors
3. Part III. From Pilot to Production
4. Index
5. Part II. The Right Tool for the Right Problem
6. Bibliography
7. Appendix B. How to Translate Evidence-Based Theories to the Design of Digitally Delivered Mental Health Interventions
8. Appendix A. AI and Its Potential Use in DTx: A Brief Overview of Frequently Asked Questions
9. 7. Clinical Validation: Unique Challenges and Novel Approaches
10. 2. Addressing Unmet Stakeholder Needs
11. Acknowledgments
12. The Right Tool for the Right Problem
13. Conclusion. The Future of DTx
14. 6. Data Sourcing and Management
15. 11. Channel Partnerships: The Ultimate Commercialization Strategy
16. 12. The Price Is Right: Value in the Eye of the Beholder
17. Paths to Commercialization
18. 10. Supporting Adoption of DTx
19. 9. Recommendations for DTx Implementation
20. 8. Factors That Influence the Implementation of New Technologies
21. From Pilot to Production
22. 5. Test, Learn, and Pivot
23. 4. Ensuring Business Viability Early
24. 3. Addressing Unmet Clinical Needs
25. Foreword. It Is Time for Health Care to Embrace Patients
26. Part I. What are Digital Therapeutics?
27. Introduction. The Context
28. 1. Digital Health Solutions versus Digital Therapeutics
29. Preface
30. Contents
31. Half Title Page, Title Page, Copyright
32. Radiation therapy with phenotypic medicine: towards N-of-1 personalization
33. Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trial
34. Personalization and localization as key expectations of digital health intervention in women pre- to post-pregnancy
35. Artificial intelligence education: An evidence-based medicine approach for consumers, translators, and developers
36. Towards machine learning for hydrogel drug delivery systems
37. Enabling Technologies for Personalized and Precision Medicine
38. AI for Drug Repurposing in the Pandemic Response
39. Involving patients in the process: Development of a constipation patient-reported outcome measure for symptoms and quality of life
40. Enhancing physical performance with machine learning
41. Safety evaluation of nanodiamond-doxorubicin complexes in a Naïve Beagle canine model using hematologic, histological, and urine analysis
42. Bottom-up design of hydrogels for programmable drug release
43. Defining the optimal time to appendectomy: A step toward precision surgery
44. The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
45. Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
46. Personal and work‐related factors associated with post‐traumatic growth in nurses: A mixed studies systematic review.
47. Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
48. Clinical validation of a nanodiamond-embedded thermoplastic biomaterial.
49. Blockchain applications in health care for COVID-19 and beyond: a systematic review
50. N-of-1 medicine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.